Not Yet RecruitingPhase 4

Impact of AHCC® Supplementation for Prevention of Respiratory Tract Infections Among Children Age 2-4 Years Old

60 participantsStarted 2026-06-01

Plain-language summary

This is a study to evaluate the effects of a prebiotic, AHCC, a standardized extract of cultured Lentinula edodes mycelia, on immunologic markers and the incidence of respiratory tract infections in children.

Who can participate

Age range2 Years – 4 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Children aged 2-4 years old at the time of enrolment
✓. Good nutritional status with weight-for-height \> -2, and height-for-age z-score \> -2 based on WHO growth standards
✓. Infants in a group setting (daycare centers).
✓. No congenital disorder
✓. Not suffering from severe coughing or diarrhoea at the time of recruitment
✓. Written informed consent will be obtained from parents or legal guardians before enrollment.

What they're measuring

Incidence of Respiratory Tract Infection

Timeframe: 3 months

Trial details

NCT IDNCT07479394

SponsorHasanuddin University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-12-31

Contact for this trial

Conny Tanjung, PhD; Consultant Pediatrician

+6281282733388 conny.tanj@gmail.com

View on ClinicalTrials.gov More Respiratory Tract Infections (RTI) trials